Dr Ellen Thomas, chief medical officer ... has a rare genetic disorder called early juvenile Metachromatic Leukodystrophy (MLD), which is part of the new screening test. Joshua was apparently ...

--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today ...

Oh has been appointed as medical director of Smilow Cancer Hospital at Greenwich Hospital ... He is committed to increasing ...

HighlightsThird quarter revenue grew 11% year-over-year to $213 million, driven by Pharmacogenomics (34%) and Prenatal (10%) and progress on ...

Meridell Achievement Center specializes in behavioral programs for adolescents. Dr. Barbara Matthews, Licensed Psychologist, spoke with Studio 512 about the use and importance of evaluating ...

Duke-NUS scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

Aliso Viejo-based Ambrey Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered ...

Zurich continues to push boundaries in Healthcare and InsureTech with the Zurich Innovation Championship (ZIC) by working ...

Illumina (ILMN) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.33 per share a year ago. These figures are ...

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...